Brussels, 04/08/2010 (Agence Europe) - On Tuesday 3 August, the European Commission authorised the planned acquisition of the German producer of generic pharmaceuticals, Ratiopharm, by the Israeli Teva, which also specialises in the production of generics. This decision is, however, subject to the divestment of fifteen products in the Netherlands and one in Hungary.
The Commission's investigations showed that most of the markets for the pharmaceutical products in question would not face any...